Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab

NCT06167642 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Tomography, Optical Coherence
Retinal Degeneration
Visual Acuity

Interventions

DRUG: Ofatumumab

Sponsor

Johns Hopkins University

Collaborators

[object Object]